Conference Abstracts
Cost utility analysis of long-term telemonitoring of patients with DMT2: Results of the Greek pilot of the renewing health multicenter pragmatic randomized trial
Authors:
George E. Dafoulas ,
Faculty of Medicine, University of Thessaly, Greece, GR
Afentoula Mavrodi,
Department of Business Administration, University of Macedonia, Thessaloniki, Greece, GR
Alexandra Bargiota,
Department of Endocrinology and Metabolic Diseases, Regional University Hospital of Larisa, Larisa, Greece, GR
Haralambos Giannakakos,
Regional University Hospital, 5th Regional Health Authority of Thessaly and Sterea, Larisa, Greece, GR
Panagiotis Stafylas,
Health Information Management SA, Bruxelles, Belgium, BE
Paraskevi Gkiata,
Telehealth Center, Intermunicipal Digital Community of Central Greece, Trikala, Greece, GR
Petros Pechlivangolou,
Toronto Health Economics and Technology Assessment Collaborative, University of Toronto, Toronto, Canada, GR
Kyriaki Theodorou,
Faculty of Medicine, University of Thessaly, Greece, GR
Georgios Koukoulis,
Department of Endocrinology and Metabolic Diseases, Regional University Hospital of Larisa, Larisa, Greece, GR
Vasilios Aletras
Department of Business Administration, University of Macedonia, Thessaloniki, Greece, GR
How to Cite:
Dafoulas GE, Mavrodi A, Bargiota A, Giannakakos H, Stafylas P, Gkiata P, et al.. Cost utility analysis of long-term telemonitoring of patients with DMT2: Results of the Greek pilot of the renewing health multicenter pragmatic randomized trial. International Journal of Integrated Care. 2014;14(8):None. DOI: http://doi.org/10.5334/ijic.1767
Published on
01 Nov 2014.
Downloads
